11180023

Source:http://linkedlifedata.com/resource/pubmed/id/11180023

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:11180023	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:11180023	lifeskim:mentions	umls-concept:C0043031	lld:lifeskim
pubmed-article:11180023	lifeskim:mentions	umls-concept:C0851347	lld:lifeskim
pubmed-article:11180023	lifeskim:mentions	umls-concept:C1280500	lld:lifeskim
pubmed-article:11180023	lifeskim:mentions	umls-concept:C0762662	lld:lifeskim
pubmed-article:11180023	pubmed:issue	6	lld:pubmed
pubmed-article:11180023	pubmed:dateCreated	2001-1-12	lld:pubmed
pubmed-article:11180023	pubmed:abstractText	The objective of this study was to examine the effect of 3 doses of rofecoxib (12.5, 25, and 50 mg) on the pharmacodynamics and pharmacokinetics of warfarin.	lld:pubmed
pubmed-article:11180023	pubmed:language	eng	lld:pubmed
pubmed-article:11180023	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:citationSubset	AIM	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11180023	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:11180023	pubmed:month	Dec	lld:pubmed
pubmed-article:11180023	pubmed:issn	0009-9236	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:De SmetMM	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:GertzB JBJ	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:VerbesseltRR	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:LULL	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:SchwartzJ IJI	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:LenaAA	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:LinsRR	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:KeymeulenBB	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:PorrasA GAG	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:LaugiéHH	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:HuntT LTL	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:EbelD LDL	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:HaesenRR	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:BugianesiK...	lld:pubmed
pubmed-article:11180023	pubmed:author	pubmed-author:DieckJJ	lld:pubmed
pubmed-article:11180023	pubmed:issnType	Print	lld:pubmed
pubmed-article:11180023	pubmed:volume	68	lld:pubmed
pubmed-article:11180023	pubmed:owner	NLM	lld:pubmed
pubmed-article:11180023	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:11180023	pubmed:pagination	626-36	lld:pubmed
pubmed-article:11180023	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:meshHeading	pubmed-meshheading:11180023...	lld:pubmed
pubmed-article:11180023	pubmed:year	2000	lld:pubmed
pubmed-article:11180023	pubmed:articleTitle	The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.	lld:pubmed
pubmed-article:11180023	pubmed:affiliation	Merck Research Laboratories, Rahway, New Jersey, USA.	lld:pubmed
pubmed-article:11180023	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:11180023	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:11180023	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:11180023	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
pubmed-article:11180023	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11180023	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11180023	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:11180023	lld:pubmed